<DOC>
	<DOC>NCT00186303</DOC>
	<brief_summary>To evaluate the role of high dose therapy and autologous or allogeneic hematopoietic cell transplantation for the treatment of chronic lymphocytic leukemia.</brief_summary>
	<brief_title>Transplantation for Patients With Chronic Lymphocytic Leukemia</brief_title>
	<detailed_description>To determine effectiveness of allogeneic transplantation in eradicating chronic lymphocytic leukemia.</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia, Lymphoid</mesh_term>
	<mesh_term>Leukemia, Lymphocytic, Chronic, B-Cell</mesh_term>
	<criteria>adequate organ function normal bone marrow cytogenetics active CNS disease For autologous patients more than 30% bone marrow involvement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>